A case of tumour necrosis factor-α inhibitor- and rituximab-induced plantar pustular psoriasis that completely resolved with tocilizumab

British Journal of Dermatology

Volumn 171, Issue 6, 2014, Pages 1546-1549

  Jayasekera, P ^a   Parslew, R ^a   Al Sharqi, A ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CLOBETASOL PROPIONATE; CYCLOSPORIN A; ETANERCEPT; ETRETIN; METHOTREXATE; MOMETASONE FUROATE; PENICILLAMINE; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB; DERMATOLOGICAL AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANGIODYSPLASIA; ARTICLE; CASE REPORT; COLONIC ANGIODYSPLASIA; CONTINUOUS INFUSION; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEMORAL HERNIA; FEVER; GOLD THERAPY; HOT FLUSH; HUMAN; HYPERTENSION; MIXED INFECTION; PLANTAR PUSTULAR PSORIASIS; PUSTULAR PSORIASIS; RHEUMATOID ARTHRITIS; RITUXIMAB INDUCED PLANTAR PUSTULAR PSORIASIS; TOE MALFORMATION; VERY ELDERLY; CHEMICALLY INDUCED; DRUG ERUPTIONS; PSORIASIS; TREATMENT OUTCOME;

AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; DERMATOLOGIC AGENTS; DRUG ERUPTIONS; FEMALE; HUMANS; PSORIASIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84919443866     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13146     Document Type: Article

References (15)

1. National Institute for Health and Care Excellence. Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198). Available at: http://www.nice.org.uk/guidance/TA247 (last accessed 27 October 2014).
2. Kawazoe Y, Sugita S, Yamada Y, et al,. Psoriasis triggered by infliximab in a patient with Behçet's disease. Jpn J Ophthalmol 2013; 57: 95-7.
3. de Gannes GC, Ghoreishi M, Pope J, et al,. Psoriasis and pustular dermatitis triggered by TNF-α in patients with rheumatologic conditions. Arch Dermatol 2007; 143: 223-31.
4. Thomas L, Canoui-Poitrine F, Gottenberg JE, et al,. Incidence of new-onset and flare of pre-existing psoriasis during rituximab. J Rheumatol 2012; 39: 893-8.
5. Dass S, Vital EM, Emery P,. Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum 2007; 56: 2715-18.
6. Olivieri I, D'Angelo S, Leccese P, et al,. Worsening of psoriasis with rituximab therapy. Clin Exp Rheumatol 2010; 28: 926.
7. Markatseli TE, Kaltsonoudis ES, Voulgari PV, et al,. Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab. Clin Exp Rheumatol 2009; 27: 996-8.
8. Rueda-Gotor J, González-Gay M, Alonso R, et al,. Successful effect of tocilizumab in anti-TNF-α-induced palmoplantar pustulosis in rheumatoid arthritis. Joint Bone Spine 2012; 79: 510-13.
9. Younis S, Rimar D, Slobodin G, Rosner I,. Tumor necrosis factor-associated palmoplantar pustular psoriasis treated with interleukin 6 blocker. J Rheumatol 2012; 39: 2055-6.
10. Hardcastle SA, Williamson L,. Atypical psoriasis following rituximab for rheumatoid arthritis. J Rheumatol 2012; 39: 1303-4.
11. Ameglio F, Bonifati C, Pietravallle M, Fazio M,. Interleukin-6 and tumour necrosis factor levels decrease in the suction blister fluids of psoriatic patients during effective therapy. Dermatology 1994; 189: 359-63.
12. Galadari I, Sheriff M,. Estimation of interleukin-6 level in psoriasis patients. Eur Ann Allergy Clin Immunol 2005; 37: 63-5.
13. Goodman W, Levine A, Massari J, et al,. IL-6 signalling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 2009; 18: 3170-6.
14. de Waal AC, van de Kerkhof PCM,. Pustulosis palmoplantaris is a disease distinct from psoriasis. J Dermatolog Treat 2011; 22: 102-5.
15. Ellingford J, Black G, Bhaskar S, et al,. Exome sequencing and network analysis identifies two candidate mutations in patients with anti-tumour necrosis factor therapy-induced palmoplantar pustulosis. Presented at the British Society of Investigative Dermatology Meeting, Newcastle, U.K., 7-9 April 2014.